Sartorius Stedim Biotech: Information on Document Availability

Regulatory News: The Investor Relations news on the first half 2017 results of Sartorius Stedim Biotech Group (BOURSE: DIM) is now available at.

Sartorius Stedim Biotech is a leading international supplier of products and services that enable the biopharmaceutical industry to develop and manufacture drugs safely and efficiently.


Read all

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.